Complete Filing Data
Passage BIO, Inc. reported Stockholders Equity of $18.76 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Passage BIO, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income Loss | -$45.5M | -$64.8M | -$102.1M | -$136.1M | -$185.4M | -$112.2M | -$45.6M |
| Operating Income Loss | -$49.3M | -$70.4M | -$108.4M | -$138.4M | -$185.7M | -$112.9M | -$37.2M |
| General And Administrative Expense | $19.9M | $25.0M | $41.6M | $49.3M | $60.1M | $30.1M | $7.0M |
| Comprehensive Income Net Of Tax | -$45.5M | -$64.7M | -$101.1M | -$136.7M | -$185.8M | -$112.2M | -$45.6M |
| Research And Development Expense Excluding Acquired In Process Cost | $61.4M | $86.1M | $117.7M | $81.8M | $29.7M | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | -$8.0K | $51.0K | $923.0K | -$553.0K | -$401.0K | -$12.0K | |
| Prepaid Research And Development Asset Current | $830.0K | $1.2M | $2.7M | $6.5M | $7.6M | $11.0M | $6.7M |
| Research And Development Asset Acquired Other Than Through Business Combination Written Off | $3.0M | $8.0M | $1.0M | $500.0K | |||
| Other Nonoperating Income Expense | $3.8M | $5.6M | $6.3M | $2.3M | |||
| Research And Development Expense | $23.3M | $40.2M | $61.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$7.7M | -$9.4M | -$15.4M | -$19.3M | -$16.0M | -$16.7M | -$27.1M | -$23.9M | -$34.3M | -$26.7M | -$39.5M | -$42.8M | -$46.9M | -$48.4M | -$38.9M | -$28.5M | -$27.2M | -$17.6M | -$11.4M | -$13.4M | -$7.7M |
| Operating Income Loss | -$8.7M | -$10.3M | -$16.5M | -$20.7M | -$17.4M | -$18.1M | -$28.7M | -$25.4M | -$35.9M | -$27.5M | -$39.8M | -$42.8M | -$47.1M | -$48.5M | -$38.9M | -$28.6M | -$27.3M | -$17.9M | -$11.6M | -$7.8M | |
| General And Administrative Expense | $4.3M | $4.5M | $6.1M | $7.3M | $6.5M | $6.5M | $8.2M | $8.1M | $19.0M | $10.7M | $13.0M | $15.1M | $15.0M | $15.4M | $12.5M | $7.8M | $7.4M | $4.8M | $1.2M | $968.0K | |
| Comprehensive Income Net Of Tax | -$7.7M | -$9.4M | -$15.4M | -$19.2M | -$16.0M | -$16.7M | -$27.0M | -$23.8M | -$33.8M | -$26.6M | -$39.8M | -$43.7M | -$46.9M | -$48.4M | -$38.9M | -$28.6M | -$27.2M | -$17.6M | -$11.4M | ||
| Research And Development Expense Excluding Acquired In Process Cost | $8.7M | $10.4M | $11.5M | $15.1M | $17.3M | $16.8M | $15.4M | $26.8M | $26.2M | $26.6M | $33.1M | $25.0M | $20.8M | $19.9M | $13.1M | $10.4M | $6.3M | ||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | -$8.0K | $99.0K | $2.0K | -$26.0K | $148.0K | $87.0K | $539.0K | $110.0K | -$244.0K | -$921.0K | $14.0K | $26.0K | $5.0K | -$40.0K | |||||||
| Prepaid Research And Development Asset Current | $1.3M | $1.3M | $1.2M | $1.2M | $1.8M | $2.0M | $1.6M | $915.0K | $2.2M | $7.3M | $9.0M | $13.1M | $8.9M | $7.2M | $10.0M | $12.1M | $12.6M | $12.3M | |||
| Research And Development Asset Acquired Other Than Through Business Combination Written Off | $1.5M | $1.5M | $5.5M | $1.5M | $500.0K | ||||||||||||||||
| Other Nonoperating Income Expense | $906.0K | $949.0K | $1.1M | $1.4M | $1.4M | $1.3M | $1.6M | $1.5M | $1.5M | ||||||||||||
| Research And Development Expense | $4.3M | $5.8M | $7.7M | $8.7M | $10.4M | $11.5M | $13.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $18.8M | $61.3M | $111.3M | $201.4M | $318.7M | $304.7M | -$56.3M | -$12.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $46.3M | $37.6M | $21.7M | $34.6M | $129.0M | $135.0M | $158.9M | $24.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $8.7M | $15.9M | -$12.9M | -$94.4M | -$6.0M | -$23.9M | $134.0M | |
| Retained Earnings Accumulated Deficit | -$704.8M | -$659.2M | -$594.5M | -$492.4M | -$356.3M | -$170.9M | -$58.7M | |
| Property Plant And Equipment Net | $4.1M | $9.3M | $15.3M | $22.5M | $23.8M | $2.8M | $1.1M | |
| Other Assets Noncurrent | $244.0K | $463.0K | $433.0K | $4.3M | $6.2M | $8.0M | $11.8M | |
| Liabilities Current | $23.1M | $19.4M | $16.3M | $18.4M | $29.5M | $21.2M | $3.7M | |
| Liabilities And Stockholders Equity | $62.3M | $102.4M | $150.5M | $243.5M | $355.1M | $328.0M | $178.6M | |
| Liabilities | $43.5M | $41.2M | $39.3M | $42.2M | $36.4M | $23.3M | $4.3M | |
| Cash And Cash Equivalents At Carrying Value | $46.3M | $37.6M | $21.7M | $34.6M | $129.0M | $135.0M | $158.9M | |
| Assets Current | $47.8M | $78.8M | $118.0M | $197.0M | $325.1M | $317.2M | $165.8M | |
| Assets | $62.3M | $102.4M | $150.5M | $243.5M | $355.1M | $328.0M | $178.6M | |
| Accrued Expenses And Other Current Liabilities | $4.7M | $6.7M | $11.7M | $11.0M | $20.1M | $15.9M | $3.1M | |
| Accounts Payable Current | $1.1M | $742.0K | $1.3M | $4.1M | $9.4M | $5.3M | $629.0K | |
| Available For Sale Securities Debt Securities Current | $0.00 | $39.2M | $92.6M | $155.0M | $186.8M | $169.8M | ||
| Marketable Securities Unrealized Gain Loss | -$8.0K | $51.0K | $923.0K | -$553.0K | -$401.0K | -$12.0K | ||
| Amortization Of Debt Discount Premium | $129.0K | -$1.5M | -$2.0M | $773.0K | $2.8M | $633.0K | ||
| Common Stock Value | $5.0K | $5.0K | $5.0K | $4.0K | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $8.0K | -$43.0K | -$966.0K | -$413.0K | -$12.0K | |||
| Prepaid Expense And Other Assets Current | $629.0K | $838.0K | $923.0K | $926.0K | $1.7M | $1.4M | ||
| Stock Issued During Period Value Vesting Of Common Stock Previously Subject To Repurchase | $45.0K | $35.0K | $100.0K | |||||
| Operating Lease Right Of Use Asset | $10.2M | $13.8M | $16.9M | $19.7M | ||||
| Operating Lease Liability Noncurrent | $20.4M | $21.8M | $22.9M | $23.8M | ||||
| Operating Lease Liability Current | $3.6M | $3.7M | $3.4M | $3.3M | ||||
| Deferred Rent Credit Noncurrent | $6.9M | $2.1M | $504.0K | |||||
| Property And Equipment In Accounts Payable And Accrued Expenses And Other Current Liabilities | $23.0K | $114.0K | $2.1M | $48.0K | ||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $422.0K | $20.4M | ||||||
| Operating Lease Liability Recognized Upon Adoption Of Standard | $422.0K | $27.3M | ||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$463.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $31.1M | $38.3M | $46.7M | $72.7M | $90.6M | $104.9M | $126.3M | $150.4M | $170.4M | $224.4M | $248.0M | $281.3M | $362.2M | $402.3M | $441.5M | $338.9M | $363.4M | $386.7M | -$44.1M | -$32.9M | -$19.6M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $52.8M | $57.6M | $63.4M | $32.3M | $24.8M | $36.8M | $33.6M | $30.3M | $33.4M | $62.6M | $91.1M | $101.6M | $162.9M | $215.5M | $249.5M | $200.6M | $353.4M | $366.8M | $177.2M | $78.8M | $43.9M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $25.8M | $15.1M | -$1.2M | -$27.4M | $114.5M | $208.0M | $19.1M | |||||||||||||||
| Retained Earnings Accumulated Deficit | -$691.8M | -$684.0M | -$674.6M | -$646.5M | -$627.2M | -$611.2M | -$577.7M | -$550.6M | -$526.7M | -$465.3M | -$438.6M | -$399.1M | -$305.1M | -$258.2M | -$209.8M | -$132.0M | -$103.4M | -$76.2M | ||||
| Property Plant And Equipment Net | $5.2M | $5.3M | $5.5M | $10.0M | $13.1M | $14.5M | $16.1M | $20.2M | $21.6M | $22.9M | $23.6M | $24.3M | $17.8M | $13.5M | $6.6M | $915.0K | $1.1M | $1.1M | ||||
| Other Assets Noncurrent | $270.0K | $270.0K | $274.0K | $463.0K | $516.0K | $662.0K | $433.0K | $433.0K | $433.0K | $4.7M | $5.2M | $5.7M | $6.7M | $7.2M | $7.6M | $8.3M | $8.8M | $9.2M | ||||
| Liabilities Current | $22.2M | $19.8M | $17.8M | $17.0M | $12.4M | $12.8M | $19.8M | $19.9M | $17.2M | $21.6M | $27.1M | $27.5M | $22.3M | $31.2M | $19.5M | $19.1M | $14.1M | $5.2M | ||||
| Liabilities And Stockholders Equity | $74.2M | $79.2M | $86.0M | $111.8M | $125.4M | $140.5M | $169.3M | $193.7M | $213.2M | $270.1M | $299.4M | $333.2M | $390.9M | $439.5M | $465.2M | $358.7M | $378.1M | $392.4M | ||||
| Liabilities | $43.0M | $40.9M | $39.3M | $39.0M | $34.8M | $35.6M | $43.0M | $43.3M | $42.9M | $45.7M | $51.4M | $51.9M | $28.7M | $37.3M | $23.7M | $19.8M | $14.7M | $5.8M | ||||
| Cash And Cash Equivalents At Carrying Value | $52.8M | $57.6M | $63.4M | $32.3M | $24.8M | $36.8M | $33.6M | $30.3M | $33.4M | $62.6M | $91.1M | $101.6M | $162.9M | $215.5M | $249.5M | $200.6M | $353.4M | $366.8M | ||||
| Assets Current | $55.7M | $60.3M | $66.7M | $87.2M | $95.0M | $108.3M | $135.7M | $153.6M | $171.6M | $222.5M | $250.6M | $283.0M | $366.5M | $418.8M | $450.9M | $349.5M | $368.2M | $382.1M | ||||
| Assets | $74.2M | $79.2M | $86.0M | $111.8M | $125.4M | $140.5M | $169.3M | $193.7M | $213.2M | $270.1M | $299.4M | $333.2M | $390.9M | $439.5M | $465.2M | $358.7M | $378.1M | $392.4M | ||||
| Accrued Expenses And Other Current Liabilities | $4.0M | $4.1M | $4.0M | $6.7M | $8.1M | $7.5M | $13.7M | $13.2M | $10.9M | $13.9M | $15.7M | $15.2M | $13.3M | $14.8M | $13.2M | $15.7M | $6.9M | $2.7M | ||||
| Accounts Payable Current | $952.0K | $2.4M | $1.5M | $1.5M | $621.0K | $1.7M | $2.7M | $3.4M | $3.0M | $4.5M | $8.2M | $9.1M | $9.0M | $16.4M | $6.2M | $3.4M | $7.2M | $2.5M | ||||
| Available For Sale Securities Debt Securities Current | $0.00 | $0.00 | $52.5M | $67.0M | $67.8M | $99.2M | $121.2M | $134.4M | $151.2M | $148.1M | $165.5M | $191.5M | $192.3M | $188.1M | $135.1M | |||||||
| Marketable Securities Unrealized Gain Loss | -$8.0K | -$26.0K | $539.0K | -$921.0K | -$5.0K | |||||||||||||||||
| Amortization Of Debt Discount Premium | $129.0K | -$444.0K | -$98.0K | $875.0K | $848.0K | |||||||||||||||||
| Common Stock Value | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $32.0K | -$67.0K | -$69.0K | -$192.0K | -$340.0K | -$427.0K | -$1.5M | -$1.6M | -$1.3M | $33.0K | $19.0K | -$7.0K | -$40.0K | |||||||||
| Prepaid Expense And Other Assets Current | $1.6M | $1.4M | $2.1M | $1.2M | $1.4M | $1.8M | $1.3M | $1.2M | $1.7M | $1.5M | $2.3M | $2.8M | $3.1M | $3.9M | ||||||||
| Stock Issued During Period Value Vesting Of Common Stock Previously Subject To Repurchase | $4.0K | $41.0K | $1.0K | $1.0K | $32.0K | $78.0K | $1.0K | $13.0K | ||||||||||||||
| Operating Lease Right Of Use Asset | $13.0M | $13.3M | $13.5M | $14.0M | $16.8M | $17.1M | $17.0M | $19.4M | $19.6M | $19.9M | $20.1M | $20.2M | ||||||||||
| Operating Lease Liability Noncurrent | $20.8M | $21.1M | $21.5M | $22.1M | $22.5M | $22.8M | $23.2M | $23.4M | $23.6M | $24.0M | $24.2M | $24.4M | ||||||||||
| Operating Lease Liability Current | $3.5M | $3.6M | $3.6M | $3.7M | $3.7M | $3.7M | $3.3M | $3.3M | $3.3M | $3.3M | $3.2M | $3.1M | ||||||||||
| Deferred Rent Credit Noncurrent | $6.5M | $6.0M | $4.2M | $643.0K | $524.0K | $489.0K | ||||||||||||||||
| Property And Equipment In Accounts Payable And Accrued Expenses And Other Current Liabilities | $36.0K | $644.0K | $420.0K | |||||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $422.0K | $20.4M | ||||||||||||||||||||
| Operating Lease Liability Recognized Upon Adoption Of Standard | $422.0K | $27.3M | ||||||||||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$500.0K | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $728.0K | $3.1M | $3.7M | $3.7M | $1.5M | $800.0K | $134.0K |
| Net Cash Provided By Used In Operating Activities | -$31.5M | -$48.0M | -$78.3M | -$118.2M | -$126.9M | -$80.5M | -$39.9M |
| Net Cash Provided By Used In Investing Activities | $40.2M | $54.9M | $65.2M | $25.2M | -$45.8M | -$172.1M | -$1.7M |
| Increase Decrease In Prepaid Research And Development | -$391.0K | -$1.5M | -$3.8M | -$1.1M | -$3.4M | $4.2M | -$1.7M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$228.0K | -$255.0K | -$3.8M | -$2.7M | -$1.8M | -$1.9M | $10.1M |
| Increase Decrease In Accounts Payable Trade | $1.9M | -$556.0K | -$2.8M | -$5.4M | $2.2M | $4.6M | $398.0K |
| Share Based Compensation | $3.0M | $5.8M | $10.9M | $19.0M | $32.7M | $14.6M | $1.5M |
| Net Cash Provided By Used In Financing Activities | $23.0K | $8.9M | $135.0K | -$1.4M | $166.7M | $228.8M | $175.6M |
| Payments To Acquire Machinery And Equipment | $34.0K | $146.0K | $2.3M | $17.6M | $1.1M | $1.2M | |
| Proceeds From Sale And Maturity Of Marketable Securities | $39.0M | $143.2M | $194.8M | $188.3M | $182.4M | $95.6M | |
| Payments To Acquire Marketable Securities | $88.2M | $129.4M | $157.8M | $202.5M | $266.1M | ||
| Proceeds From Stock Options Exercised | $35.0K | $129.0K | $301.0K | $284.0K | $176.0K | ||
| Proceeds From Stock Plans | $23.0K | $97.0K | $135.0K | $304.0K | $887.0K | $208.0K | |
| Increase Decrease In Right Of Use Assets And Operating Lease Liabilities | $464.0K | $279.0K | $133.0K | -$463.0K | |||
| Stock Issued During Period Value Share Based Compensation | $35.0K | $129.0K | $301.0K | ||||
| Payments To Acquire Intangible Assets | $3.0M | $8.0M | $500.0K | $500.0K | |||
| Increase Decrease In Deferred Rent | $2.1M | $259.0K | $452.0K | ||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$2.1M | -$5.0M | $659.0K | -$7.3M | |||
| Increase Decrease In Accrued Expenses And Other Current Liabilities | -$7.3M | $4.0M | $12.2M | $2.0M | |||
| Proceeds From Issuance Of Common Stock | $165.8M | $228.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $200.0K | $200.0K | $201.0K | $800.0K | $800.0K | $806.0K | $1.0M | $1.0M | $978.0K | $900.0K | $900.0K | $883.0K | $211.0K | $49.0K | $12.0K | ||
| Net Cash Provided By Used In Operating Activities | -$13.8M | -$18.9M | -$22.4M | -$44.7M | -$30.7M | -$21.9M | -$214.0K | ||||||||||
| Net Cash Provided By Used In Investing Activities | $39.6M | $25.3M | $21.2M | $17.3M | -$20.4M | -$99.0K | -$884.0K | ||||||||||
| Increase Decrease In Prepaid Research And Development | -$30.0K | -$758.0K | -$4.3M | $5.5M | -$975.0K | $5.6M | -$2.9M | ||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $709.0K | $1.1M | -$3.1M | $624.0K | $1.4M | $978.0K | -$31.0K | ||||||||||
| Increase Decrease In Accounts Payable Trade | $716.0K | $389.0K | -$1.0M | -$957.0K | $592.0K | $331.0K | -$47.0K | ||||||||||
| Share Based Compensation | $858.0K | $1.6M | $2.8M | $6.3M | $9.7M | $2.4M | $231.0K | ||||||||||
| Net Cash Provided By Used In Financing Activities | $8.7M | $49.0K | $165.6M | $229.9M | $20.2M | ||||||||||||
| Payments To Acquire Machinery And Equipment | $26.0K | $725.0K | $801.0K | $99.0K | $884.0K | ||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $39.0M | $39.1M | $72.6M | $56.9M | $41.2M | ||||||||||||
| Payments To Acquire Marketable Securities | $13.8M | $51.4M | $37.4M | $60.3M | |||||||||||||
| Proceeds From Stock Options Exercised | $49.0K | $81.0K | $44.0K | $176.0K | |||||||||||||
| Proceeds From Stock Plans | |||||||||||||||||
| Increase Decrease In Right Of Use Assets And Operating Lease Liabilities | $97.0K | $45.0K | $21.0K | -$418.0K | |||||||||||||
| Stock Issued During Period Value Share Based Compensation | $35.0K | $79.0K | $49.0K | $44.0K | $104.0K | ||||||||||||
| Payments To Acquire Intangible Assets | $1.5M | $500.0K | |||||||||||||||
| Increase Decrease In Deferred Rent | -$647.0K | -$15.0K | $444.0K | ||||||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$2.7M | -$4.2M | $1.9M | -$4.8M | |||||||||||||
| Increase Decrease In Accrued Expenses And Other Current Liabilities | -$4.8M | -$3.7M | -$426.0K | ||||||||||||||
| Proceeds From Issuance Of Common Stock | $165.8M | $229.9M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$14.35 | -$21.04 | -$1.86 | -$2.50 | -$3.48 | -$2.91 | -$10.77 |
| Common Stock Shares Outstanding | 3.2M | 3.2M | 54.9M | 54.6M | 54.2M | 45.6M | 4.3M |
| Common Stock Shares Issued | 3.2M | 3.2M | 54.9M | 54.6M | 54.2M | 45.9M | 5.2M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 3.2M | 3.1M | 54.7M | 54.4M | 53.3M | 38.6M | |
| Weighted Average Number Of Diluted Shares Outstanding | 3.2M | 3.1M | 54.7M | 54.4M | 53.3M | 38.6M | |
| Earnings Per Share Basic | $-14.35 | $-21.04 | $-1.86 | $-2.50 | $-3.48 | $-2.91 | |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 38.6M | 4.2M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.44 | -$2.96 | -$0.25 | -$6.15 | -$5.09 | -$0.30 | -$0.49 | -$0.44 | -$0.63 | -$0.49 | -$0.73 | -$0.79 | -$0.87 | -$0.90 | -$0.76 | -$0.63 | -$0.60 | -$1.00 | -$2.68 | -$3.19 |
| Common Stock Shares Outstanding | 3.2M | 3.2M | 62.1M | 61.8M | 61.8M | 61.6M | 54.8M | 54.7M | 54.6M | 54.5M | 54.5M | 54.3M | 54.0M | 54.0M | 53.8M | 45.5M | 45.4M | 45.4M | ||
| Common Stock Shares Issued | 3.2M | 3.2M | 62.1M | 61.8M | 61.8M | 61.6M | 54.8M | 54.7M | 54.6M | 54.5M | 54.5M | 54.3M | 54.1M | 54.1M | 54.0M | 45.9M | 45.8M | 45.8M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 3.2M | 3.2M | 62.1M | 3.1M | 3.1M | 56.3M | 54.8M | 54.7M | 54.6M | 54.5M | 54.4M | 54.3M | 54.0M | 53.9M | 51.3M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 3.2M | 3.2M | 62.1M | 3.1M | 3.1M | 56.3M | 54.8M | 54.7M | 54.6M | 54.5M | 54.4M | 54.3M | 54.0M | 53.9M | 51.3M | |||||
| Earnings Per Share Basic | $-2.44 | $-2.96 | $-0.25 | $-6.15 | $-5.09 | $-0.30 | $-0.49 | $-0.44 | $-0.63 | $-0.49 | $-0.73 | $-0.79 | $-0.87 | $-0.90 | $-0.76 | |||||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 54.0M | 53.9M | 51.3M | 45.5M | 45.4M | 17.6M | 4.2M | 4.2M | ||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.0M | $5.8M | $10.9M | $19.0M | $32.7M | $14.6M | $1.5M |
| Additional Paid In Capital | $723.5M | $720.5M | $705.8M | $694.7M | $675.3M | $475.6M | $2.4M |
| Stock Issued During Period Value Employee Stock Purchase Plan | $23.0K | $97.0K | $135.0K | $304.0K | $887.0K | $284.0K | |
| Investment Income Interest | $343.0K | $670.0K | $696.0K | ||||
| Stock Issued During Period Value New Issues | $8.7M | $165.8M | $227.5M | ||||
| Vesting Of Early Exercise Option Awards | $45.0K | $35.0K | $100.0K | ||||
| Stock Issuance Costs | $669.0K | $3.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $611.0K | $923.0K | $858.0K | $1.4M | $1.6M | $1.6M | $2.8M | $3.7M | $2.8M | $2.9M | $6.3M | $6.3M | $6.8M | $8.6M | $9.7M | $4.0M | $3.9M | $2.4M | $95.0K | $92.0K | $231.0K |
| Additional Paid In Capital | $722.9M | $722.3M | $721.3M | $719.2M | $717.8M | $716.1M | $704.2M | $701.3M | $697.5M | $691.2M | $688.3M | $681.7M | $667.3M | $660.5M | $651.3M | $470.9M | $466.8M | $462.9M | |||
| Stock Issued During Period Value Employee Stock Purchase Plan | $14.0K | $50.0K | $89.0K | $79.0K | $243.0K | $505.0K | |||||||||||||||
| Investment Income Interest | $1.0K | $186.0K | $99.0K | $52.0K | $99.0K | $132.0K | $327.0K | $255.0K | |||||||||||||
| Stock Issued During Period Value New Issues | $8.7M | $165.8M | $227.5M | ||||||||||||||||||
| Vesting Of Early Exercise Option Awards | $41.0K | $32.0K | $13.0K | ||||||||||||||||||
| Stock Issuance Costs | $669.0K | $3.5M | $102.0K |
Most recent annual filing with the SEC: March 3, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.